Homo sapiens Protein: REL | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||
InnateDB Protein | IDBP-53135.5 | ||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||
Gene Symbol | REL | ||||||||||||||||||||||
Protein Name | v-rel reticuloendotheliosis viral oncogene homolog (avian) | ||||||||||||||||||||||
Synonyms | C-Rel; | ||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||
Ensembl Protein | ENSP00000295025 | ||||||||||||||||||||||
InnateDB Gene | IDBG-53133 (REL) | ||||||||||||||||||||||
Protein Structure | |||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||
Function | Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF- kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF- kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The NF-kappa-B heterodimer RELA/p65-c-Rel is a transcriptional activator. | ||||||||||||||||||||||
Subcellular Localization | Nucleus {ECO:0000250}. | ||||||||||||||||||||||
Disease Associations | |||||||||||||||||||||||
Tissue Specificity | |||||||||||||||||||||||
Comments | |||||||||||||||||||||||
Interactions | |||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 132 experimentally validated interaction(s) in this database.
They are also associated with 36 interaction(s) predicted by orthology.
|
||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||
InterPro |
IPR000451
NF-kappa-B/Rel/Dorsal IPR002909 IPT domain IPR008967 p53-like transcription factor, DNA-binding IPR011539 Rel homology domain IPR014756 Immunoglobulin E-set |
||||||||||||||||||||||
PFAM |
PF01833
PF00554 |
||||||||||||||||||||||
PRINTS |
PR00057
|
||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||
SMART |
SM00429
|
||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||
Modification | |||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||
SwissProt | Q04864 | ||||||||||||||||||||||
PhosphoSite | PhosphoSite-Q04864 | ||||||||||||||||||||||
TrEMBL | |||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||
Entrez Gene | 5966 | ||||||||||||||||||||||
UniGene | Hs.631886 | ||||||||||||||||||||||
RefSeq | NP_002899 | ||||||||||||||||||||||
HUGO | HGNC:9954 | ||||||||||||||||||||||
OMIM | 164910 | ||||||||||||||||||||||
CCDS | CCDS1864 | ||||||||||||||||||||||
HPRD | 01286 | ||||||||||||||||||||||
IMGT | |||||||||||||||||||||||
EMBL | DQ314888 M11595 X75042 | ||||||||||||||||||||||
GenPept | AAA52073 ABC40747 CAA52954 | ||||||||||||||||||||||